Valuation: AstraZeneca PLC

Market Cap 263B 230B 212B 195B 368B 25,299B 377B 2,532B 996B 12,369B 987B 965B 42,701B P/E 2026 *
21.2x
P/E 2027 * 18.6x
Enterprise Value 282B 247B 228B 210B 395B 27,147B 404B 2,717B 1,069B 13,273B 1,059B 1,036B 45,820B EV / Sales 2026 *
4.46x
EV / Sales 2027 * 4.11x
Free-Float
96.63%
Yield 2026 *
1.97%
Yield 2027 * 2.08%

Last Transcript: AstraZeneca PLC

1 day-0.27%
1 week-1.87%
Current month-10.68%
1 month-4.26%
3 months-16.70%
6 months-10.38%
Current year-8.67%
1 week 11,870
Extreme 11870
12,810
1 month 11,870
Extreme 11870
14,686
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Free

See Remarks

2 0.0000%
6/8/26 Free

See Remarks

1 0.0000%
5/20/26 Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%-1.87%+22.34%+22.51% 263B
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
-0.36%+3.64%+2.37%-30.88% 143B
Average -0.10%+0.85%+25.92%+45.43% 371.78B
Weighted average by Cap. +0.34%+0.16%+36.16%+75.39%

Financials

2026 *2027 *
Net sales 63.21B 55.3B 51.09B 47.02B 88.63B 6,085B 90.66B 609B 240B 2,975B 237B 232B 10,271B 66.79B 58.43B 53.98B 49.68B 93.64B 6,430B 95.79B 644B 253B 3,144B 251B 245B 10,852B
Net income 12.43B 10.88B 10.05B 9.25B 17.43B 1,197B 17.83B 120B 47.12B 585B 46.68B 45.66B 2,020B 13.94B 12.19B 11.26B 10.37B 19.54B 1,342B 19.99B 134B 52.82B 656B 52.34B 51.18B 2,265B
Net Debt 19.2B 16.79B 15.51B 14.28B 26.91B 1,848B 27.53B 185B 72.76B 903B 72.08B 70.5B 3,119B 11.9B 10.41B 9.62B 8.85B 16.69B 1,146B 17.07B 115B 45.11B 560B 44.7B 43.71B 1,934B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-17 GBX 12,594.00 -0.27% 2,012,949
26-07-16 GBX 12,628.00 +0.49% 1,602,666
26-07-15 GBX 12,566.00 +1.63% 3,346,169
26-07-14 GBX 12,364.00 -1.95% 3,313,274
26-07-13 GBX 12,610.00 -1.75% 2,741,916
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
169.43USD
Average target price
212.13USD
Spread / Average Target
+25.20%

Quarterly revenue - Rate of surprise